These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 3087666)

  • 1. Inherited enzyme deficiencies and immunodeficiency: adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiencies.
    Hirschhorn R
    Clin Immunol Immunopathol; 1986 Jul; 40(1):157-65. PubMed ID: 3087666
    [No Abstract]   [Full Text] [Related]  

  • 2. ADA and PNP deficiencies: how it all began.
    Giblett ER
    Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.
    Hirschhorn R
    Birth Defects Orig Artic Ser; 1983; 19(3):73-81. PubMed ID: 6418227
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunodeficiency secondary to adenosine deaminase deficiency and purine nucleoside phosphorylation deficiency.
    Carson DA; Carrera CJ
    Semin Hematol; 1990 Jul; 27(3):260-9. PubMed ID: 2115692
    [No Abstract]   [Full Text] [Related]  

  • 5. Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states.
    Goldblum RM; Schmalstieg FC; Nelson JA; Mills GC
    Birth Defects Orig Artic Ser; 1978; 14(6A):73-84. PubMed ID: 215243
    [No Abstract]   [Full Text] [Related]  

  • 6. [Congenital immunodeficiency with adenosine deaminase and purine nucleoside phosphorylase deficiency].
    Sakura N; Usui T; Ito K
    Nihon Rinsho; 1977 Aug; 35(8):2564-80. PubMed ID: 411964
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Shanon A; Levin S; Holtzman F; Brock-Sinai F; Abu-Said A
    Arch Dis Child; 1988 Aug; 63(8):931-4. PubMed ID: 3137899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Congenital immunodeficiency syndrome with adenosine deaminase and purine nucleoside phosphorylase deficiencies (1)].
    Sakura N; Usui T; Ito K
    Nihon Rinsho; 1977 Jul; 35(7):2397-403. PubMed ID: 411963
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
    Hirschhorn R; Ratech H
    Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean.
    Giblett ER
    Ciba Found Symp; 1978; (68):3-18. PubMed ID: 115664
    [No Abstract]   [Full Text] [Related]  

  • 11. High risk screening of adenosine deaminase and purine nucleoside phosphorylase deficiency in Japan.
    Kishi T; Sakura N; Ito K; Usui T
    Acta Paediatr Jpn; 1987 Feb; 29(1):152-4. PubMed ID: 3144840
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzyme defects in purine metabolism and immunodeficiencies.
    Ito K
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1764-71. PubMed ID: 3939170
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for primary immunodeficiencies associated with purine nucleoside phosphorylase deficiency or adenosine deaminase deficiency.
    Ito K; Sakura N; Usui T; Uchino H
    J Lab Clin Med; 1977 Nov; 90(5):844-8. PubMed ID: 409794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune deficiencies secondary to enzymopathies].
    Pérignon JL; Hamet M
    Ann Pediatr (Paris); 1989 Jun; 36(6):381-5. PubMed ID: 2502942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
    Zegers BJ; Stoop JW
    Clin Biochem; 1983 Feb; 16(1):43-7. PubMed ID: 6407780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary immunodeficiencies and purine metabolism].
    Romo Cortina A; Lorente Toledano F; Salazar Villalobos V
    Rev Clin Esp; 1985 Oct; 177(6):247-53. PubMed ID: 3001848
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress in understanding the mechanism of immunodeficiency disease associated with defects in purine metabolism.
    Seegmiller JE
    Monogr Hum Genet; 1978; 10():88-91. PubMed ID: 102926
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzyme defects and immune dysfunction.
    Rosen FS
    Nature; 1978 Dec; 276(5688):559-60. PubMed ID: 102999
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).
    Carson DA; Kaye J; Seegmiller JE
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5677-81. PubMed ID: 202960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.